End of this page section.

Begin of page section: Contents:

Patents

1.Noe C., Kreuter J., Zimmer A., Zobel H-P., Stieneker F., Atmaca-Abdel Aziz S.,
Partikuläre Arzneiform
EP 0808174 B1 (1996)

Download

2.Zimmer A., Zobel H-P., Stieneker F., Atmaca-Abdel Aziz S.,
Medicament in particle form
WO9624377 A1 (1996)

Download

3.Junghans M., Zimmer A., und Kreuter J.
Synthetisches Nucleinsäurepartikel
DE 198 58 005 A1 (1998)

Download

4.Junghans M., Zimmer A., und Kreuter J.
Synthetic Nucleic Acid Particle
EP 1 141 367 B8 (1999)

Download

5.Zimmer A., Wernig K., Wegscheider S., und Matous H.
Stabilisierte Flüssigformulierung
WO2009130048 A1 (2009)
6.Berhart E., Eder H., Mrfka M., Sattler W., Zimmer A., Reischl D.
Compounds reducing or inhibiting the expression of PKD1 for diagnosis and therapy of brain tumors
EP2297311 A1 (2009)
7.Khinast J., Brenn G., Zimmer A., Eichinger R., Bauer W.
A system and method for manufacturing a medication
EP2313050 B1 (2009)
8.Roblegg E., Zimmer A., Khinast J., Klein Th., and Jäger E.
Oral Timed-Release Formulation
WO2012159142 (A1) (2011)
9.Becker K., Haack D., Salar Behzadi S., Zimmer A..
Oral pharmaceutical composition comprising taste-masked N-Acetylcysteine
EP13163638 (2013)
10.Becker, K., Haack, D., Salar-Behzadi, S., Zimmer, A., Dandl, K., Lang, C.
Taste-masked oral pharmaceutical composition
EPC 14173273.5-1455 (2014)

Contact

Institute of Pharmaceutical Sciences
Universitätsplatz 1/EG A-8010 Graz
Pharmaceutical Technology & Biopharmacy Phone:+43 (0)316 380 - 8880
Fax:+43 (0)316 380 - 9100

Further

End of this page section.

Begin of page section: Additional information:


End of this page section.